Covered recipient · General Payments record
TANUJA PURI
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$3,060.58
- Reported across 133 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $676.98 | 33 |
| Education | $119.00 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $532.35 | 26 |
| Janssen Biotech, Inc. | $118.94 | 2 |
| Ipsen Biopharmaceuticals, Inc | $50.55 | 2 |
| Phathom Pharmaceuticals, Inc. | $38.44 | 2 |
| AIMMUNE THERAPEUTICS, INC. | $31.04 | 2 |
| Ferring Pharmaceuticals Inc. | $24.66 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $27.42 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108046472 | CMS |
| ABBVIE INC. | $5.38 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108046474 | CMS |
| ABBVIE INC. | $12.38 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108046476 | CMS |
| ABBVIE INC. | $28.83 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108046478 | CMS |
| ABBVIE INC. | $14.40 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108046480 | CMS |
| ABBVIE INC. | $17.20 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108046482 | CMS |
| ABBVIE INC. | $15.26 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108046484 | CMS |
| ABBVIE INC. | $13.75 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108046486 | CMS |
| ABBVIE INC. | $9.31 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108046488 | CMS |
| ABBVIE INC. | $22.72 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108046490 | CMS |
| ABBVIE INC. | $15.90 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108046492 | CMS |
| ABBVIE INC. | $21.58 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108046494 | CMS |
| ABBVIE INC. | $3.57 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108046496 | CMS |
| ABBVIE INC. | $14.66 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108046498 | CMS |
| ABBVIE INC. | $25.60 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108046500 | CMS |
| ABBVIE INC. | $18.88 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108046502 | CMS |
| ABBVIE INC. | $15.07 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108046504 | CMS |
| ABBVIE INC. | $105.81 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108046506 | CMS |
| ABBVIE INC. | $23.17 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108046508 | CMS |
| ABBVIE INC. | $4.33 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108046510 | CMS |
| ABBVIE INC. | $15.00 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108046512 | CMS |
| ABBVIE INC. | $18.52 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108046514 | CMS |
| ABBVIE INC. | $25.62 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108046516 | CMS |
| ABBVIE INC. | $18.47 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108046518 | CMS |
| ABBVIE INC. | $18.45 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108046520 | CMS |
| ABBVIE INC. | $21.07 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108046522 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $16.38 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146985862 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $14.66 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146985267 | CMS |
| Ferring Pharmaceuticals Inc. | $24.66 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137541472 | CMS |
| Ipsen Biopharmaceuticals, Inc | $30.55 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091977028 | CMS |
| Ipsen Biopharmaceuticals, Inc | $20.00 | 06/17/2024 | Education | Undisputed | 01/23/2026 | 1091977026 | CMS |
| Janssen Biotech, Inc. | $99.00 | 06/20/2024 | Education | Undisputed | 01/23/2026 | 1078347487 | CMS |
| Janssen Biotech, Inc. | $19.94 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078347314 | CMS |
| Phathom Pharmaceuticals, Inc. | $18.02 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151198417 | CMS |
| Phathom Pharmaceuticals, Inc. | $20.42 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151198419 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.